ABEO$4.354.61%-0.21
After Hours: 4.41+0.06 +1.38%
Abeona Therapeutics Inc (ABEO)
Date: 2026-10-30 16:00O: 4.50H: 4.53L: 4.31C: 4.35Vol: 782.8k
Abeona Therapeutics Inc stock is traded at $4.35, with a volume of 782,809. It is down -4.61% in the last 24 hours and down -17.14% over the past month. Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.
Previous Close:
$4.56
Open:
$4.50
24h Volume:
782,809
Relative Volume:
0.99
Market Cap:
$248.75M
Revenue:
$5.82M
Net Income/Loss:
$71.18M
P/E Ratio:
4.36
EPS:
$0.9972
Net Cash Flow:
-$84.30M
1W Performance:
-1.14%
1M Performance:
-17.14%
6M Performance:
-20.33%
1Y Performance:
-14.37%
1-Day Range:
$4.31$4.53
1-Week Range:
$4.30$4.73
52-Week Range:
$4.00$7.65
Abeona Therapeutics Inc Stock (ABEO) Company Profile
Name
Abeona Therapeutics IncSector
HealthcareIndustry
BiotechnologyPhone
646-813-4701Address
6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, NY, USACompare ABEO vs VRTX, REGN, MRNA, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABEO Abeona Therapeutics Inc | $4.35 | $248.75M | $5.82M | $71.18M | -$84.30M | $0.9972 |
 VRTX Vertex Pharmaceuticals Inc | $558.88 | $141.65B | $12.34B | $4.34B | $3.71B | $16.87 |
 REGN Regeneron Pharmaceuticals Inc | $927.89 | $95.53B | $14.92B | $4.42B | $3.79B | $41.04 |
 MRNA Moderna Inc | $221.72 | $88.52B | $2.23B | -$3.19B | -$1.60B | -$8.15 |
 ARGX Argen X Se Adr | $892.87 | $56.15B | $4.16B | $1.29B | $734.26M | $19.58 |
 ONC Beone Medicines Ltd Adr | $370.33 | $41.89B | $5.76B | $514.49M | $1.10B | $4.48 |
Abeona Therapeutics Inc Stock (ABEO) Upgrades & Downgrades
Abeona Therapeutics Inc Stock (ABEO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Abeona Therapeutics Inc Stock (ABEO) Insider Trading
- Seshadri VishwasSep 29 '26Officer
- Transaction
- Proposed Sale
- Cost
- $5.16
- #Shares
- 19,608
- Value ($)
- 101,091
- #Shares Total
- 0
- Vazzano Joseph WalterSep 29 '26Officer
- Transaction
- Proposed Sale
- Cost
- $5.16
- #Shares
- 9,191
- Value ($)
- 47,385
- #Shares Total
- 0
- Vasanthavada MadhavSep 29 '26Chief Commercial Officer
- Transaction
- Sale
- Cost
- $5.16
- #Shares
- 4,902
- Value ($)
- 25,273
- #Shares Total
- 285,721
- O'Malley Brendan M.Sep 29 '26SVP, Chief Legal Officer
- Transaction
- Sale
- Cost
- $5.16
- #Shares
- 6,727
- Value ($)
- 34,682
- #Shares Total
- 421,226
- Vazzano Joseph WalterSep 29 '26Chief Financial Officer
- Transaction
- Sale
- Cost
- $5.16
- #Shares
- 9,191
- Value ($)
- 47,385
- #Shares Total
- 482,888
- O'Malley Brendan M.Sep 29 '26Officer
- Transaction
- Proposed Sale
- Cost
- $5.16
- #Shares
- 6,727
- Value ($)
- 34,682
- #Shares Total
- 0
- Vasanthavada MadhavSep 29 '26Officer
- Transaction
- Proposed Sale
- Cost
- $5.16
- #Shares
- 4,902
- Value ($)
- 25,273
- #Shares Total
- 0
- Alvino MarkSep 01 '26Director
- Transaction
- Proposed Sale
- Cost
- $5.86
- #Shares
- 15,000
- Value ($)
- 87,966
- #Shares Total
- 0
- Alvino MarkSep 01 '26Director
- Transaction
- Sale
- Cost
- $5.86
- #Shares
- 15,000
- Value ($)
- 87,966
- #Shares Total
- 62,065
- Vazzano Joseph WalterJul 21 '26Chief Financial Officer
- Transaction
- Sale
- Cost
- $6.53
- #Shares
- 1,478
- Value ($)
- 9,651
- #Shares Total
- 492,079
